ASTHMA SEVERITY AND INCREASED RISK OF CARDIOVASCULAR AND CEREBROVASCULAR OUTCOMES IN PATIENTS WITH MODERATE-TO-SEVERE PERSISTENT ASTHMA.

被引：0
|
作者：
Omachi, T. A.
Haselkorn, T.
Miller, D. P.
Shah, M.
Eisner, M. D.
Chen, H.
Iribarren, C.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2014年 / 113卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P45
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [31] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
    Corren, Jonathan
    Castro, Mario
    O'Riordan, Thomas
    Hanania, Nicola A.
    Pavord, Ian D.
    Quirce, Santiago
    Chipps, Bradley E.
    Wenzel, Sally E.
    Thangavelu, Karthinathan
    Rice, Megan S.
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Maroni, Jaman
    Rowe, Paul
    Lu, Yufang
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 516 - 526
  • [32] Omalizumab Responder Analysis In Chinese Patients With Moderate-To-Severe Asthma
    Li, J.
    Kang, J.
    Wang, C.
    Yang, J.
    Wang, L.
    Humphries, M.
    Greenberg, S.
    Zhong, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [33] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
    Miller, Mechelle A.
    Davis, Karla L.
    PEDIATRICS, 2020, 146 : S375 - S375
  • [34] Omalizumab (Xolair®) increased the time to first exacerbation in patients with moderate-to-severe asthma compared with placebo
    O'Brien, JA
    Fox, H
    Thirlwell, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S107 - S107
  • [35] Content Validity of the Asthma Daytime Symptom Diary and Asthma Nighttime Symptom Diary in Patients With Moderate-to-Severe Asthma
    Keeley, T.
    Cristancho, R. Alfonso
    Mandaknallikar, P.
    Forde, K.
    Elwick, H.
    Gater, A.
    Leventi, A.
    Lawrie, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [36] Assessing Asthma Management Knowledge in Caregivers of Children with Moderate-to-Severe Asthma
    Kanaley, Madeleine K.
    Boon, Kathy L.
    Blumenstock, Jesse A.
    Bozen, Alexandria
    Chadha, Avneet S.
    Newmark, Pamela J.
    Szkodon, Jolanta W.
    Kan, Kristin
    Vojta, Deneen
    Gupta, Ruchi S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB196 - AB196
  • [37] Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab
    Chen, Hubert
    Eisner, Mark D.
    Haselkorn, Tmirah
    Trzaskoma, Benjamin
    RESPIRATORY MEDICINE, 2013, 107 (01) : 60 - 67
  • [38] Cost Comparison Among Moderate or Severe Persistent Asthma Patients With and Without Asthma Exacerbations
    Ivanova, J. I.
    Bergman, R. E.
    Birnbaum, H. G.
    Colice, G. L.
    Silverman, R.
    McLaurin, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [39] Cellular composition of induced sputum in severe persistent asthma.
    Holgate, ST
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A700 - A700
  • [40] Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Jain, Neal
    Sher, Lawrence D.
    Mao, X.
    Liu, D.
    Zhang, Yi
    Khan, Asif H.
    Kapoor, Upender
    Khokhar, Faisal A.
    Rowe, Paul J.
    Deniz, Yamo
    Ruddy, Marcella
    Laws, Elizabeth
    Patel, Naimish
    Weinreich, David M.
    Yancopoulos, George D.
    Amin, Nikhil
    Mannent, Leda P.
    Lederer, David J.
    Hardin, Megan
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2230 - 2240
12345